Hospice Agencies Available for Sale Nationwide
A 2026 analysis of hospice and home health valuation multiples across the U.S. market. This report breaks down EBITDA multiples, explains how revenue ties into valuation, compares hospice vs home health trends, and outlines what buyers and sellers need to know in 2026.
Understanding your EBITDA and its multiples is crucial to valuing your company. By leveraging peer groups such as Collective54 and partnering with Vallexa Advisors, business owners gain real-world benchmarks and expert guidance to sell confidently and for top dollar.